Substantial impact of altered pharmacokinetics in critically Ill patients on the antibacterial effects of meropenem evaluated via the dynamic hollow-fiber infection model

Search results

• Finished

  Centre for REdefining antibiotic use to reDUce resistanCE and prolong the lives of antibiotics (REDUCE)

  Roberts, J. A. (Primary Chief Investigator (PCI)), Lipman, J. (Chief Investigator (CI)), Peake, S. (Chief Investigator (CI)), Turnidge, J. D. (Chief Investigator (CI)), Slavin, M. A. (Chief Investigator (CI)), Hopkins, P. M. A. (Chief Investigator (CI)), Landersdorfer, C. (Chief Investigator (CI)), Paul, S. K. (Chief Investigator (CI)), De Waele, J. (Chief Investigator (CI)), Joynt, G. (Chief Investigator (CI)) & Udy, A. (Associate Investigator (AI))

  1/12/15 → 30/11/20

  Project: Research

• Combating bacterial 'superbugs' by innovative antibiotic combination strategies

  Landersdorfer, C. (Primary Chief Investigator (PCI))

  NHMRC - National Health and Medical Research Council (Australia)

  1/01/14 → 31/12/17

  Project: Research

• Dosing to maximise bacterial killing and prevent resistance in ICU

  Kirkpatrick, C. (Primary Chief Investigator (PCI)), Bergen, P. (Chief Investigator (CI)), Landersdorfer, C. (Chief Investigator (CI)) & Wirth, H.-J. (Chief Investigator (CI))

  NHMRC - National Health and Medical Research Council (Australia)

  1/01/14 → 31/12/16

  Project: Research

• Combating bacterial 'superbugs' by innovative dosing strategies that combine available antibiotics to prevent resistance

  Landersdorfer, C. (Primary Chief Investigator (PCI)), Boyce, J. (Chief Investigator (CI)), Bulitta, J. B. B. (Chief Investigator (CI)), Kirkpatrick, C. (Chief Investigator (CI)), Nation, R. (Chief Investigator (CI)), Oliver, A. (Chief Investigator (CI)) & Velkov, T. (Chief Investigator (CI))

  NHMRC - National Health and Medical Research Council (Australia)

  1/01/13 → 31/12/16

  Project: Research